(Q45423492)

14 December 2017

Acute pancreatitis associated with different combination therapies in patients infected with human immunodeficiency virus (English)

1 reference

14 December 2017

1 reference

Jeff J Guo

1

1 reference

14 December 2017

Raymond Jang

series ordinal

2

1 reference

14 December 2017

Anthony Louder

series ordinal

3

1 reference

14 December 2017

Robert J Cluxton

series ordinal

4

1 reference

14 December 2017

language of work or name

English

0 references

publication date

1 August 2005

1 reference

14 December 2017

1 reference

14 December 2017

25

1 reference

14 December 2017

8

1 reference

14 December 2017

1044-1054

1 reference

Acute pancreatitis in human immunodeficiency virus-infected patients: a review

14 December 2017

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.2005.25.8.1044

Acute pancreatitis in HIV-seropositive patients: a case control study of 44 patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.2005.25.8.1044

Pancreatitis in pediatric human immunodeficiency virus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.2005.25.8.1044

Incidence of pancreatitis in HIV-infected patients receiving nucleoside reverse transcriptase inhibitor drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.2005.25.8.1044

Plasmapheresis in the treatment of an acute pancreatitis due to protease inhibitor-induced hypertriglyceridemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.2005.25.8.1044

Hyperlipidemia associated with protease inhibitor therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.2005.25.8.1044

Acute pancreatitis as a complication of ritonavir therapy in a patient with AIDS.

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.2005.25.8.1044

Value of epidemiologic studies in determining the true incidence of adverse events. The nonsteroidal anti-inflammatory drug story.

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.2005.25.8.1044

Impact of cisapride label changes on codispensing of contraindicated medications.

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.2005.25.8.1044

Drug-induced pancreatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.2005.25.8.1044

Hepatobiliary and pancreatic infections in AIDS: Part one.

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.2005.25.8.1044

Pathophysiology of Alcohol-Induced Pancreatic Injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.2005.25.8.1044

Acute Pancreatitis during Primary HIV-1 Infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.2005.25.8.1044

Severe acute pancreatitis related to the use of nelfinavir in HIV infection: report of a case with positive rechallenge

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.2005.25.8.1044

10.1592/PHCO.2005.25.8.1044

21 January 2018

Identifiers

DOI

1 reference

14 December 2017

1 reference